CrushSCI.com
提供学术论文选刊润色服务
CARDIOVASCULAR DRUGS AND THERAPY 期刊封面 医学
返回期刊列表

Review Cycle Records

CARDIOVASCULAR DRUGS AND THERAPY

Springer SCIE 非OA
2026新锐 3区2025中科院 3区2025 JCR Q2
55.9平均天数
55.5中位天数
17最短天数
102最长天数
1612025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

102 天

Injectable Lipid-Lowering Therapies in Advanced Chronic Kidney Disease: Efficacy, Safety and the Dialysis Paradox

作者Aikaterini Damianaki; Emelina Stambolliu; Panagiotis Iliakis; Panagiotis Theofilis; Aggeliki Vakka; Evangelia Kalliakouda; Polykarpos Christos Patsalis; Dimitrios Konstantinidis; Dimitrios Petras

作者单位1. Nephrology Department, Hippokration General Hospital of Athens, Athens, Greece; 2. First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, Greece; 3. Department of Medicine, Division of Cardiology, Angiology and Internal Emergency Medicine, 3. Ruhr University Bochum, Knappschaft Kliniken University Hospital Bochum, Bochum, Germany

PDF源文件 DOI 网页
33 天

Limitations in PAR1-Targeted Screening of Antithrombotic Phytochemicals

作者Arienmughare Oghenetega; Nimrah Bhatti; Hira Khalid; Emmanuel Edigberhi; Osamagbe Osaghae; Khurrum Shabbir

作者单位1. Department of Medicine, University of Benin, Benin City, Nigeria; 2. Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan; 3. Department of Molecular Biology and Genetics, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan; 4. Department of Medicine, Rawal Institute of Health Sciences, Islamabad, Pakistan

PDF源文件 DOI 网页
23 天

From Hypothesis-generating to Decision-grade: Making Finerenone–spironolactone Comparisons in HFpEF Globally Implementable

作者M. Vijayasimha; M. Srikanth; Gurjeet Singh

作者单位1. University Institute of Allied Health Science, Chandigarh University, Gharuan, Mohali, India; 2. Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, India

PDF源文件 DOI 网页
91 天

Lipoprotein (a) and Coronary Atherosclerosis in Intracoronary Imaging - YELLOW II – Lp(a) Study

作者Chen Gurevitz; Yuliya Vengrenyuk; Shingo Minatoguchi; Keisuke Yasumura; Amit Hooda; Prakash Krishnan; Pedro Moreno; Jagat Narula; Samin Sharma; Robert S. Rosenson; Annapoorna S. Kini

作者单位1. Metabolism and Lipids Program, The Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, USA; 2. The Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, USA; 3. UTHealth Sciences Center, Houston, USA; 4. Mount Sinai Hospital, New York, USA

PDF源文件 DOI 网页
93 天

Dapagliflozin Inhibits Thrombin Induced ADAM17 Phosphorylation and Downstream ERK/p-c-Jun-mediated CTGF Induction to Prevent Neointimal Hyperplasia

作者Ting-Lin Yen; Po-Ching Chou; Chia-Ti Tsai; Yi-Ling Chen; Chieh-Yu Chen; Yi-Fan Chien; Wen-Chin Ko

作者单位1. Department of Medical Research, Cathay General Hospital, Taipei City, Taiwan; 2. Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 3. Division of Interventional Cardiology, Department of Cardiovascular Center, Cathay General Hospital, Taipei City, Taiwan; 4. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; 5. Division of Cardiac Electrophysiology, Department of Cardiovascular Center, Cathay General Hospital, Taipei City, Taiwan; 6. Division of General Cardiology, Department of Cardiovascular Center, Cathay General Hospital, Taipei City, Taiwan; 7. Department of Internal Medicine, Cathay General Hospital, Taipei City, Taiwan; 8. School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan

PDF源文件 DOI 网页
17 天

Between Complexity and Translation: A Reflection on Cardiac EV Signaling, Subtype Function, and the Path to Clinical Validation

作者Wenbin Lian; Yuangang Qiu

作者单位1. The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China; 2. The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China; 3. Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, China

PDF源文件 DOI 网页
22 天

Precision Secondary Prevention after Myocardial Infarction: Who Still Benefits from β-Blockade?

作者Qiaoqiao Zheng; Yiqun Lou

作者单位1. Department of Cardiovascular Medicine, XianJu People’s Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People’s Hospital, Affiliated Xianju’s Hospital, Hangzhou Medical College, Xianju Zhejiang, China

PDF源文件 DOI 网页
67 天

N-Lac-Phe Ameliorates Myocardial Cell Death by Improving Mitochondrial Dysfunction, Ultimately Improving TAC-induced Heart Failure

作者Lei Sha; Anning Du; Xiaoying Xu; Zhu Li; Biao Xu; Lina Kang

作者单位1. Department of Cardiology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China; 2. Department of Cardiology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China

PDF源文件 DOI 网页
54 天

Targeting SIRT3 in Diabetic Cardiomyopathy: Mechanism-Based Therapeutic Strategies

作者Xiaofang Zhang; Hui Lin; Xinrou Yu; Tiantian Lu; Jun Wang; Hui Ji; Dihua Huang; Dajun Lou

作者单位1. Department of Endocrinology, Shaoxing People’s Hospital, The First Affiliated Hospital of Shaoxing University, Shaoxing, China; 2. School of Medicine, Shaoxing University, Shaoxing, China; 3. Department of Cardiology, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China; 4. Department of Cardiology, Zhuji Affiliated Hospital of Wenzhou Medical University, Shaoxing, China; 5. Department of Pharmacy, Shaoxing People’s Hospital, Shaoxing, China

PDF源文件 DOI 网页
57 天

The 2025 ESC/EAS Dyslipidaemia Focused Update: Clinical Interpretation and Practical Implications

作者Luca Bonanni; Ada Cutolo; Nicola Ferri

作者单位1. Department of Medicine, Venice, Italy; 2. Department of Medicine, University of Padova, Padova, Italy; 3. Department of Cardiology, Venice, Italy

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。